ethinyl estradiol has been researched along with Hyperandrogenism in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (12.96) | 18.2507 |
2000's | 16 (29.63) | 29.6817 |
2010's | 28 (51.85) | 24.3611 |
2020's | 3 (5.56) | 2.80 |
Authors | Studies |
---|---|
Álvarez-Blasco, F; de Lope Quiñones, S; Escobar-Morreale, HF; Fernández-Durán, E; Insenser, M; Luque-Ramírez, M; Martínez-García, MÁ; Nattero-Chávez, L; Ortiz-Flores, AE; Quintero-Tobar, A | 1 |
Alesi, S; Forslund, M; Melin, J; Mousa, A; Pena, A; Piltonen, T; Romualdi, D; Tay, CT; Teede, H; Witchel, S | 1 |
Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
Bitzer, J; Lopes da Silva Filho, A; Römer, T | 1 |
Mueck, AO | 1 |
Asiimwe, A; Bezemer, ID; Herings, RMC; Penning-van Beest, FJA; Smits, E | 1 |
Canu, E; Fulghesu, AM; Melis, F; Melis, GB; Murru, G | 1 |
Amiri, M; Kabir, A; Nahidi, F; Ramezani Tehrani, F; Shekofteh, M | 1 |
Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G | 1 |
Busacca, M; De Cicco, S; Gagliano, D; Guido, M; Lanzone, A; Romualdi, D | 1 |
Caruso, S; Cianci, A; Cianci, S; Cicero, C; Lo Presti, L; Malandrino, C | 1 |
Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
Jin, J; Mueck, AO; Ruan, X; Wu, H | 1 |
de Zegher, F; Díaz, M; Gallego-Escuredo, JM; Ibáñez, L; Villarroya, F | 1 |
Bottiglieri, P; Colao, A; Colarieti, G; Giallauria, F; Muscogiuri, G; Orio, F; Palomba, S; Predotti, P; Savastano, S; Tafuri, D | 1 |
Asiimwe, A; Cea Soriano, L; García Rodriguez, LA | 1 |
Bilchugova, E; Colonna, L; Guardianelli, F; Lello, S; Pallotta, P; Primavera, G; Raskovic, D; Sorge, R; Vittori, G | 1 |
Cao, Y; Jiang, Y; Wu, J; Zhu, Y | 1 |
Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
Colonna, L; Guardianelli, F; Lello, S; Primavera, G; Raskovic, D; Sorge, R; Vittori, G | 1 |
de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A | 1 |
Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V | 1 |
Decavalas, G; Diamanti-Kandarakis, E; Georgopoulos, NA; Katsikis, I; Panidis, D; Piouka, A; Saltamavros, AD | 1 |
Colonna, L; Guardianelli, F; Lello, S; Melis, GB; Pacifico, V; Paoletti, AM; Primavera, G; Raskovic, D; Sorge, R | 1 |
Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
de Zegher, F; Diaz, M; Ibáñez, L; Lopez-Bermejo, A; Salvador, C; Sánchez-Infantes, D; Sebastiani, G | 1 |
Lages, L; Maier, PS; Mattiello, SS; Spritzer, PM | 1 |
Chacón, MR; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Maymó-Masip, E; Salvador, C; Vendrell, J | 1 |
Bruni, V; Dei, M; Fambrini, M; Nannini, S; Peruzzi, E; Seravalli, V; Sisti, G | 1 |
DiVasta, AD; Veilleux-Lemieux, M | 1 |
Maier, PS; Spritzer, PM | 1 |
Herer, P; Luboshitzky, R; Shen-Orr, Z | 2 |
Carmina, E; Lobo, RA | 1 |
Chen, W; Thiboutot, D | 1 |
le Roux, PA; Van der Spuy, ZM | 1 |
de Zegher, F; Ibáñez, L | 2 |
Cabré, S; De Zegher, F; Ibáñez, L; Valls, C | 1 |
Kuhl, H; Wiegratz, I | 1 |
Cianci, A; De Leo, V; Morgante, G; Musacchio, MC; Petraglia, F; Piomboni, P | 1 |
Rich, P | 1 |
Anania, C; Elkind-Hirsch, KE; Mack, M; Malinak, R | 1 |
Falsetti, L; Pasinetti, E | 1 |
Gerhard, I; Matthes, J; Runnebaum, B | 1 |
Angioni, S; Deiana, P; Genazzani, AR; Grasso, A; Mauri, A; Silferi, M; Volpe, A | 1 |
Wilson, L; Zemtsov, A | 1 |
Gjønnaess, H | 1 |
Bakas, P; Creatsas, G; Gregoriou, O; Konidaris, S; Mathiopoulos, D; Papadias, K | 1 |
Gogate, JG; Shringi, MS; Vaidya, AB; Vaidya, RA | 1 |
Boudou, P; Chaspoux, C; Fiet, J; Hardy, N; Jouanique, C; Reygagne, P; Vexiau, P | 1 |
8 review(s) available for ethinyl estradiol and Hyperandrogenism
Article | Year |
---|---|
Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Testosterone | 2023 |
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Skin Diseases; Treatment Outcome | 2017 |
Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Progestins; Regression Analysis; Sex Hormone-Binding Globulin; Treatment Outcome | 2018 |
Update and future of hormonal therapy in acne.
Topics: Acne Vulgaris; Androgen Antagonists; Androgens; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone; Estradiol Congeners; Ethinyl Estradiol; Glucocorticoids; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Sebum; Spironolactone | 2003 |
Cyproterone acetate for hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Randomized Controlled Trials as Topic | 2003 |
Metabolic and clinical effects of progestogens.
Topics: Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Metabolism; Progestins; Renin-Angiotensin System; Thromboembolism | 2006 |
Hormonal contraceptives for acne management.
Topics: Acne Vulgaris; Androstenes; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Skin | 2008 |
28 trial(s) available for ethinyl estradiol and Hyperandrogenism
Article | Year |
---|---|
Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bloodletting; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypertension; Polycystic Ovary Syndrome; Young Adult | 2021 |
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases | 2013 |
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.
Topics: Adolescent; Adult; Androstenes; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Ethinyl Estradiol; Female; Glucose Clamp Technique; Hirsutism; Humans; Hyperandrogenism; Pilot Projects; Polycystic Ovary Syndrome; Triglycerides | 2013 |
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.
Topics: Adolescent; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Fibroblast Growth Factors; Flutamide; Hirsutism; Humans; Hyperandrogenism; Hyperinsulinism; Longitudinal Studies; Metformin; Pioglitazone; Thiazolidinediones | 2016 |
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adult; Androstenes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Contraceptives, Oral; Ethinyl Estradiol; Exercise; Female; Humans; Hyperandrogenism; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2016 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio | 2008 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Androstenedione; Androstenes; Chlormadinone Acetate; Dehydroepiandrosterone Sulfate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hair; Humans; Hyperandrogenism; Luteinizing Hormone; Sex Hormone-Binding Globulin; Skin Diseases; Testosterone; Young Adult | 2008 |
Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
Topics: Adolescent; Androgen Antagonists; Androstenes; Body Composition; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Flutamide; Follistatin; Humans; Hyperandrogenism; Hyperinsulinism; Metformin; Young Adult | 2011 |
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult | 2010 |
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Anti-Mullerian Hormone; Blood Glucose; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Young Adult | 2011 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Body Composition; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Metformin; Pioglitazone; Thiazolidinediones; Treatment Outcome | 2011 |
17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Topics: 3-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Aldo-Keto Reductase Family 1 Member C3; Brazil; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Genetic Association Studies; Hirsutism; Humans; Hydroxyprostaglandin Dehydrogenases; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Young Adult | 2012 |
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Angiopoietin-Like Protein 4; Angiopoietins; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Body Composition; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Gene Expression; Humans; Hyperandrogenism; Hypoglycemic Agents; Leptin; Metformin; Pioglitazone; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Subcutaneous Fat; Thiazolidinediones; TWEAK Receptor | 2012 |
Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Melatonin | 2002 |
Treatment of hyperandrogenic alopecia in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Italy; Liver; Testosterone | 2003 |
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Topics: Adiponectin; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Androstenes; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Hormone Antagonists; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Interleukin-6; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Proteins | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Topics: Adiponectin; Adolescent; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipolysis; Metformin; Polycystic Ovary Syndrome; Proteins | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
Topics: Adolescent; Adult; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Lipolysis; Metformin; Polycystic Ovary Syndrome; Time Factors | 2005 |
Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism.
Topics: Adolescent; Adult; Contraceptives, Oral; Drug Therapy, Combination; Endometrium; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Leuprolide; Luteinizing Hormone; Norethindrone; Ovarian Diseases; Testosterone | 1995 |
Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Topics: Adult; Apoproteins; Cholesterol; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipid Metabolism; Lipoproteins; Polycystic Ovary Syndrome; Pregnancy; Testosterone; Triglycerides | 1995 |
The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive.
Topics: Adult; Buserelin; Contraceptives, Oral, Combined; Cyproterone Acetate; Down-Regulation; Drug Combinations; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Infertility, Female; Infusion Pumps; Ovulation Induction | 1993 |
The effect of combined oral contraception with or without spironolactone on bone mineral density of hyperandrogenic women.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcium; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Luteinizing Hormone; Osteocalcin; Phosphates; Spironolactone | 2000 |
Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Topics: Administration, Topical; Adult; Alopecia; Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Minoxidil | 2002 |
18 other study(ies) available for ethinyl estradiol and Hyperandrogenism
Article | Year |
---|---|
Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome | 2017 |
Thrombotic risk minimization for Diane-35 and generics.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Drug Utilization; Drugs, Generic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Menstruation Disturbances; Middle Aged; Netherlands; Retrospective Studies; Risk Reduction Behavior; Thrombosis; Young Adult | 2017 |
Very low dose of flutamide in the treatment of hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Androstenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Treatment Outcome; Young Adult | 2018 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Hyperandrogenic women treated with a continuous-regimen oral contraceptive.
Topics: Acne Vulgaris; Adolescent; Androgens; Androstenes; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2013 |
Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Topics: Adolescent; Adult; Androgen Antagonists; China; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metabolome; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2015 |
Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; General Practice; Hirsutism; Humans; Hyperandrogenism; Off-Label Use; Polycystic Ovary Syndrome; Retrospective Studies; United Kingdom; Young Adult | 2017 |
[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg].
Topics: Adolescent; Adult; Androstenes; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Severity of Illness Index; Skin; Treatment Outcome | 2008 |
[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism].
Topics: Administration, Oral; Adolescent; Adult; Androstenes; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females.
Topics: Adolescent; Adult; Alanine Transaminase; Androgen Antagonists; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Norpregnenes; Population Surveillance; Risk Factors; Young Adult | 2012 |
Severe hyperandrogenemia and insulin resistance in a 12-year-old girl.
Topics: Child; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Testosterone | 2012 |
Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
Topics: Adult; Androgens; Anovulation; Aromatase; Blood Pressure; Body Mass Index; Contraceptives, Oral; Ethinyl Estradiol; Female; Gene Frequency; Genotype; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Phenotype; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Spironolactone; Young Adult | 2012 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Prospective Studies | 2007 |
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.
Topics: Acne Vulgaris; Adolescent; Adult; Apolipoproteins A; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinopeptide A; Humans; Hyperandrogenism; Sex Hormone-Binding Globulin | 1994 |
Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Insulin Resistance; Remission Induction; Spironolactone; Syndrome | 1997 |
Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Electrocoagulation; Estrogens; Ethinyl Estradiol; Female; Gonadotropins; Humans; Hyperandrogenism; Infertility, Female; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1999 |
Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Diabetes Mellitus; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Hypertension; Insulin Resistance; Progesterone Congeners; Syndrome | 1997 |